Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber

Conclusion MP-AzeFlu had a more rapid onset of action (5 minutes) and was more effective than LORA/INFP. Registration of the trial ClinicalTrials.gov Identifier: NCT03004131; Key words: allergic rhinitis, azelastine, environmental exposure chamber, fluticasone propionate, loratadine, onset of action
Source: The Journal of Allergy and Clinical Immunology: In Practice - Category: Allergy & Immunology Source Type: research